Jane Street
IGC icon

Jane Street’s IGC Pharma IGC Stock Holding History

Jane Street’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,600
Closed -$17K – 10408
2021
Q3 		$17K Buy
+11,600
New +$18.8K ﹤0.01% 9763

Other funds holding IGC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's IGC Position: Q3 2025 in Review

Jane Street sold out of IGC Pharma (IGC) in Q3 2025, closing a stake of 13,316 shares — an estimated $4.08K sold.

Jane Street first reported a position in IGC in Q3 2018 and held it in 14 quarters. The position peaked at $137K in Q3 2018. 35 funds tracked by Wall St. Rank hold IGC as of Q3 2025.

  • Jane Street reported no remaining IGC Pharma position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 13,316 IGC Pharma shares in Q3 2025, an estimated $4.08K.
  • Jane Street first reported a position in IGC Pharma in Q3 2018 and held it in 14 quarters.
  • Jane Street's IGC Pharma position peaked at $137K in Q3 2018.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.